Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 02, 2021
Takeda announced the completion of its previously-announced sale of a portfolio of select products sold in Latin America to Hypera for a total value of $825 million USD.
read more
Wednesday, March 04, 2020
Takeda Pharmaceutical announced the completion of its previously-announced sale of a portfolio of select products to STADA Arzneimittel for a total value of $660 million USD.
read more
Takeda has officially opened a new manufacturing plant at its site at Grange Castle, in Dublin, Ireland.
read more
Takeda announced the opening of a new research facility in San Diego, California.
read more
Takeda Pharmaceutical Company has announced a partnership with the Bill & Melinda Gates Foundation to support global polio eradication in developing countries. With this funding, Takeda will develop, license and supply at least 50 million doses per ...
read more
Ovid announced the closing of the Royalty, License and Termination agreement under which Takeda secured global rights from Ovid to develop and commercialize soticlestat.
read more
Takeda and Biological E. Limited have entered into a licensing agreement to expedite the development and delivery of affordable combination vaccines.
read more
Takeda and BioSurfaces have entered into an agreement to initiate a research program designed to develop innovative medical devices to treat patients with GI diseases using BioSurfaces’ proprietary nanomaterial technology.
read more
Thursday, August 03, 2017
Takeda and Molecular Templates announced a collaboration agreement for oncology drug discovery programs.
read more
Takeda and Schrödinger announced the formation of a multi-target research collaboration directed to diseases that align with Takeda’s core therapeutic areas of interest.
read more
Takeda Pharmaceutical and Seattle Genetics announced the Phase 3 ECHELON-1 clinical trial met its primary endpoint of a statistically significant improvement in modified PFS versus the control arm.
read more
Wednesday, April 23, 2025
Tanner Pharma Group has announced the opening of its new US operations facility in Charlotte, NC. This purpose-built, 22,000+ square foot facility represents a significant investment in enhancing the company’s secondary packaging, labeling, storage ...
read more
Wednesday, December 02, 2015
Tanner Pharma Group has announced the hiring of Jonathan Bracey as Managing Director – UK, effective 1 December, 2015.
read more
Tanner Pharma Group has announced the signing of a distribution agreement with Partner Therapeutics, (PTx), an integrated biopharmaceutical company.
read more
Tanner Pharma has announced the signing of a distribution agreement with Nephcentric, a developer and marketer of evidence based therapeutic options for people with kidney disease and metabolic disorders.
read more